Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 1/20 | 0.39 |
| ▸ | LPAR3 | Q9UBY5 | 6/20 | 0.38 |
| ▸ | LPAR1 | Q92633 | 5/20 | 0.38 |
| ▸ | USP2 | O75604 | 1/20 | 0.37 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.37 |
| ▸ | LPAR2 | Q9HBW0 | 3/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | CNR1 | P21554 | 1/20 | 0.36 |
| ▸ | CNR2 | P34972 | 1/20 | 0.36 |
| ▸ | LPAR5 | Q9H1C0 | 2/20 | 0.35 |
| ▸ | LPAR6 | P43657 | 1/20 | 0.35 |
| ▸ | LPAR4 | Q99677 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7134973 | 1.00 | DNM1 (0.39) | DNM1LPAR3LPAR1USP2SPHK1 | |
| SCHEMBL28027780 | 0.98 | DNM1 (0.42) | DNM1LPAR3LPAR1USP2SPHK1 | |
| SCHEMBL19668160 | 0.94 | CYP3A4 (0.36) | DNM1LPAR3LPAR1SPHK1ALDH1A1 | |
| SCHEMBL30535779 | 0.87 | DNM1 (0.47) | DNM1LPAR3LPAR1USP2SPHK1 | |
| SCHEMBL28329768 | 0.87 | DNM1 (0.47) | DNM1LPAR3LPAR1USP2SPHK1 | |
| SCHEMBL9546960 | 0.87 | DNM1 (0.47) | DNM1LPAR3LPAR1USP2SPHK1 | |
| SCHEMBL3147596 | 0.87 | DNM1 (0.47) | DNM1LPAR3LPAR1USP2SPHK1 | |
| SCHEMBL4312227 | 0.87 | DNM1 (0.47) | DNM1LPAR3LPAR1USP2SPHK1 | |
| SCHEMBL8735235 | 0.85 | DNM1 (0.45) | DNM1LPAR3LPAR1USP2SPHK1 | |
| Propene SCHEMBL23500981 | 0.85 | HPGD (0.35) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3630057-A1 | PERFUMES IN THE FORM OF AQUEOUS MICROEMULSIONS | Chanel Parfums Beauté (FR) | 2020-04-08 | — | — | EP | disclosed |
| EP-3463585-A1 | PERFUMES IN THE FORM OF AQUEOUS MICROEMULSIONS | Chanel Parfums Beauté (FR) | 2019-04-10 | — | — | EP | disclosed |
| EP-3463586-A1 | PERFUMES IN THE FORM OF AQUEOUS MICROEMULSIONS | Chanel Parfums Beauté (FR) | 2019-04-10 | — | — | EP | disclosed |
| WO-2018220147-A1 | PERFUMES IN THE FORM OF AQUEOUS MICROEMULSIONS | CHANEL PARFUMS BEAUTE (FR) | 2018-12-06 | — | — | WO | disclosed |
| WO-2017207935-A1 | PERFUMES IN THE FORM OF AQUEOUS MICROEMULSIONS | CHANEL PARFUMS BEAUTE (FR) | 2017-12-07 | — | — | WO | disclosed |
| WO-2017207936-A1 | PERFUMES IN THE FORM OF AQUEOUS MICROEMULSIONS | CHANEL PARFUMS BEAUTE (FR) | 2017-12-07 | — | — | WO | disclosed |
| EP-1253130-B1 | Method for producing 3-l-menthoxypropane-1,2-diol | TAKASAGO PERFUMERY CO LTD (JP) | 2005-11-02 | — | — | EP | disclosed |
| CN-1182948-C | Process for preparing porous prepolymer pellets | ͨ�õ�����˾ | 2005-01-05 | — | — | CN | disclosed |
| US-6515188-B2 | Reacting l-menthol with 1,2-epoxy-3-halogenopropane in an organic solvent and Lewis acid, the product is reacted with a alkali metal salt of a carboxyalkyl acid, followed by hydrolysis | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2003-02-04 | — | — | US | disclosed |
| CN-1382176-A | Method of crystallizing polycarbonate prepolymer | GEN ELECTRIC (US) | 2002-11-27 | — | — | CN | disclosed |
| CN-1378498-A | Method of preparing porous prepolymer pellets | GEN ELECTRIC (US) | 2002-11-06 | — | — | CN | disclosed |
| EP-1253130-A2 | Method for producing 3-l-menthoxypropane-1,2-diol | Takasago International Corporation (JP) | 2002-10-30 | — | — | EP | disclosed |
| US-20020156327-A1 | Method for producing 3-l-menthoxypropane-1,2-diol | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2002-10-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020156327-A1 | Method for producing 3-l-menthoxypropane-1,2-diol | LOXL2, FAAH2, LOXL1 | DNM1 968/4885LPAR3 174/4885LPAR1 141/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.